Closed
You're reading the free version. Trader adds the live tape and alerts. Start tracking
Sale
Calculated transaction value
$490.78K

Rothblatt Martine A Chairperson & CEO

Transaction date Aug 5, 2026
Public filing date Aug 6, 2026
Filing lag Filed 1 day later

UTHR daily price context

Close on/before transaction
$519.01 Aug 5, 2026
First close after public filing
$538.84 Aug 7, 2026
30-day return after filing
-7.58% Through Sep 8, 2026

Source details

Reported owner
Not disclosed
Source asset code
Security
Security
Common Stock
Quantity / price
939 shares @ $522.66
SEC ownership
Indirect
Transaction code
S
Form
4
Filing identifier
0001106578-26-000114
Filing cohort

Transactions in this filing

Showing 15 of 18
Trades
18
Issuers
1
Estimated value
$6.21M
Buys / sales
0 / 16
Transactions reported in the same official filing
Issuer Transaction Traded Value
United Therapeutics Corp UTHR Exercise Aug 5, 2026 $1.29M
United Therapeutics Corp UTHR Sale Aug 5, 2026 $100.46K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $40.34K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $272.05K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $105.67K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $777.35K
United Therapeutics Corp UTHR Current Sale Aug 5, 2026 $490.78K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $136.73K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $83.93K
United Therapeutics Corp UTHR Exercise Aug 5, 2026 $0
United Therapeutics Corp UTHR Sale Aug 5, 2026 $81.64K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $199.46K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $288.24K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $980.5K
United Therapeutics Corp UTHR Sale Aug 5, 2026 $81.16K